ArticleFrontiers in oncology2024

Combined aqupla, paclitaxel liposome, and docetaxel treatment: survival and biomarker outcomes in recurrent ovarian cancer patients.

Jie Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.